Magseed for Breast Cancer Treatment
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 65 (estimated)
- Sponsor
- Endomagnetics Ltd. · Industry
This trial is looking for patients with breast cancer who are planning to undergo chemotherapy. Participants will have a special marker placed in their lymph nodes to help guide surgery later on.
You may be able to join if
- I am 18 years or older.
- I have been diagnosed with breast cancer.
- I have lymph node metastasis confirmed by a biopsy.
- A clip was placed in my lymph node before starting chemotherapy.
- I am planning to receive neo-adjuvant chemotherapy.
- I am eligible for targeted axillary dissection after chemotherapy.
- My performance status is ECOG 0-2.
You may not be able to join if
- I have distant metastases.
- I have inflammatory breast cancer.
- I have had prior surgery on the same side of my axilla.
- I have a history of breast cancer in the same breast.
- I have a history of lymphoma.
- I am pregnant.
- I have had radiation to my breast or axilla.
- I have a pacemaker or other implantable cardiac device in my chest.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThe purpose of this study is to provide prospective evidence that the use of Magseed/Sentimag in marking axillary lymph nodes and guiding surgical localization in patients with breast cancer following neo-adjuvant chemotherapy (NAC) is effective.
Loading trial locations…